ECSP18071568A - Agente microbiano de suministro directo para la prevención de una patología del camarón - Google Patents

Agente microbiano de suministro directo para la prevención de una patología del camarón

Info

Publication number
ECSP18071568A
ECSP18071568A ECSENADI201871568A ECDI201871568A ECSP18071568A EC SP18071568 A ECSP18071568 A EC SP18071568A EC SENADI201871568 A ECSENADI201871568 A EC SENADI201871568A EC DI201871568 A ECDI201871568 A EC DI201871568A EC SP18071568 A ECSP18071568 A EC SP18071568A
Authority
EC
Ecuador
Prior art keywords
shrimp
pathology
prevention
direct supply
supply agent
Prior art date
Application number
ECSENADI201871568A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP18071568A publication Critical patent/ECSP18071568A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a cepas de Bacillus subtilis y su uso para el tratamiento de una patología del camarón tal como el síndrome de mortalidad temprana.
ECSENADI201871568A 2016-02-23 2018-09-21 Agente microbiano de suministro directo para la prevención de una patología del camarón ECSP18071568A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662298578P 2016-02-23 2016-02-23

Publications (1)

Publication Number Publication Date
ECSP18071568A true ECSP18071568A (es) 2018-10-31

Family

ID=58231730

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201871568A ECSP18071568A (es) 2016-02-23 2018-09-21 Agente microbiano de suministro directo para la prevención de una patología del camarón

Country Status (3)

Country Link
CN (1) CN108603166A (es)
EC (1) ECSP18071568A (es)
WO (1) WO2017147130A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019040266A1 (en) * 2017-08-23 2019-02-28 Novozymes A/S MICROBIENT AGENTS DIRECTLY FEED TO IMPROVE THE GENERAL CONDITION AND HEALTH OF FISH
WO2019132605A1 (ko) * 2017-12-29 2019-07-04 씨제이제일제당 (주) 바실러스 서브틸리스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 또는 흰반점 증후군의 예방 또는 치료용 사료 조성물
KR102277987B1 (ko) * 2017-12-29 2021-07-16 씨제이제일제당 주식회사 바실러스 서브틸리스 균주, 바실러스 푸밀러스 균주 및 바실러스 리체니포미스 균주를 유효성분으로 포함하는 급성 췌장염 괴사증 (ahpnd) 또는 흰반점 증후군(wss)의 예방 또는 치료용 사료 조성물
GB201911925D0 (en) * 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
CN111690558B (zh) * 2020-05-31 2022-04-08 青岛玛斯特生物技术有限公司 一株枯草芽孢杆菌菌株及其在水产养殖中的应用
CN112251370B (zh) * 2020-09-03 2023-08-04 福建大北农华有水产科技集团有限公司 含有枯草芽孢杆菌的复合微生态制剂及其应用
CN112602859A (zh) * 2020-12-28 2021-04-06 东台市苏泰饲料有限公司 一种防控对虾肝胰腺坏死综合症饲料
CN116286447B (zh) * 2022-10-09 2024-09-27 集美大学 一株枯草芽孢杆菌及其应用
CN116948890B (zh) * 2023-07-13 2024-03-22 江苏三仪生物工程有限公司 一种抑制水产弧菌的复合微生态菌剂及其制备方法
CN117844673B (zh) * 2023-11-18 2024-10-22 江苏省海洋水产研究所 一种拮抗副溶血性弧菌的枯草芽孢杆菌jshy-k3及复合制剂和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155468A2 (en) * 2012-04-12 2013-10-17 Dupont Nutrition Biosciences Aps Microbial strains and their use in animals

Also Published As

Publication number Publication date
WO2017147130A2 (en) 2017-08-31
WO2017147130A3 (en) 2017-10-19
CN108603166A (zh) 2018-09-28

Similar Documents

Publication Publication Date Title
ECSP18071568A (es) Agente microbiano de suministro directo para la prevención de una patología del camarón
ECSP21033236A (es) Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad de nlrp
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
CL2016002027A1 (es) Ciclopropilamina como inhibidor de la lsd1
CL2017003404A1 (es) Compuestos antibacterianos
CL2018002698A1 (es) Tratamiento de enfermedades inflamatorias con inhibidores de actividad c5a
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
CO2017013446A2 (es) Composiciones que comprenden cepas bacterianas del género bacteroides
CL2016001933A1 (es) Compuestos derivados de macrociclos, inhibidores del factor xia composición farmacéutica que los comprende y su uso en el tratamiento yo profilaxis de una enfermedad tromboembolica. pct
CL2016002516A1 (es) “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct
MX2018014476A (es) Cepa de bacillus subtilis con actividad probiotica.
MX394441B (es) Una formulación a base de besifloxacina para usarse en el tratamiento del acné resistente a fármacos
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
CL2016002091A1 (es) Compuesto de triazina y su uso para fines medicinales
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
MX2019009908A (es) Combinacion de un agonista de ppar con un agonista de fxr.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
CL2018001470A1 (es) Vacunación con el dominio alfa 3 de mica/b para el tratamiento del cáncer
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.